Literature DB >> 69399

Hepatocellular carcinoma in the Rhodesian African.

G E Thomas, A C Wicks, D J Clain, N Loon, J Seggie, B Bramstom.   

Abstract

We have carried out a prospective survey of 28 primary liver carcinomas over one year. Hepatocellular carcinoma is the commonest malignancy seen in Rhodesian blacks, which results in a high index of suspicion and accounts for the 96.4% positive diagnosis before death in this study. The age distribution was evenly spread through adult life with no definite peak incidence. Some were young and without evidence of chronic liver disease, but many had the stigmata of established hepatic disease. This contrasts with the common assertion that in areas of high incidence for primary liver cancer those affected are mainly young and lack signs of chronic liver disease. The commonest presenting symptoms were abdominal pain and swelling and weight loss. Hepatomegaly, often tender and nodular, was present in all but one. The incidence of alpha-feto protein, 46.5%, is low compared with other countries where primary liver cancer is common. Hepatitis B antigen was absent in all 28, suggesting that there is no association between the persistence of the antigen and hepatocellular carcinoma in Rhodesia. Liver function tests, although abnormal, were never diagnostic of primary liver cancer. We have confirmed the association of high alcohol consumption and cirrhosis with hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69399     DOI: 10.1007/BF01073074

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  53 in total

1.  Comparison of liver cancer and cirrhosis in nine areas in trans-Saharan Africa.

Authors:  P E STEINER
Journal:  Acta Unio Int Contra Cancrum       Date:  1961

2.  Studies on hypoglycaemia in primary carcinoma of the liver. A case report and review of pathogenetic mechanisms.

Authors:  A I Vinik; W M Deppe
Journal:  S Afr Med J       Date:  1974-03-31

3.  Hepatitis-associated antigen in hepatoma in South Vietnam.

Authors:  J D Welsh; J D Brown; K Arnold; A M Chandler
Journal:  Lancet       Date:  1972-03-11       Impact factor: 79.321

4.  Australia antigen in Singapore Chinese patients with hepatocellular carcinoma.

Authors:  M J Simons; M Yu; B K Chew; A Y Tan; E H Yap; C S Seah; W P Fung; K Shanmugaratnam
Journal:  Lancet       Date:  1971-06-05       Impact factor: 79.321

5.  Hepatitis-associated antigen in chronic liver disease.

Authors:  S J Hadziyannis; G E Merikas; A P Afroudakis
Journal:  Lancet       Date:  1970-07-11       Impact factor: 79.321

Review 6.  Australia antigen as a hepatitis virus. Variation in host response.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965

7.  Alcohol: a cause of diabetes in Rhodesia.

Authors:  A C Wicks; R F Lowe; J J Jones
Journal:  S Afr Med J       Date:  1974-06-01

8.  Australia antigen--Rhodesia. 2. Survey of urban blood donors and rural populations.

Authors:  J G Cruickshank; R Swanepoel; R F Lowe; T Robertson; H Moore
Journal:  Cent Afr J Med       Date:  1972-06

9.  Australia antigen--Rhodesia. 1. Pilot survey.

Authors:  J G Cruickshank; R Swanepoel
Journal:  Cent Afr J Med       Date:  1971-10

10.  Serum alpha-feto protein (alpha-FP) and hepatoma in Rhodesian Africans.

Authors:  J Seggie; M Gelfand
Journal:  Trans R Soc Trop Med Hyg       Date:  1975       Impact factor: 2.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.